Design and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin After Large Myocardial Infarction (REVEAL) trial

BACKGROUND: Acute myocardial infarction (MI) remains a leading cause of death despite advances in pharmacologic and percutaneous therapies. Animal models of ischemia/reperfusion have demonstrated that single-dose erythropoietin (EPO) may reduce infarct size, decrease apoptosis, and increase neovascu...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Melloni, Chiara, Rao, Sunil V., Povsic, Thomas J., Melton, Laura, Kim, Raymond J., Kilaru, Rakhi, Patel, Manesh, Talan, Mark, Ferrucci, Luigi, Longo, Dan L., Lakatta, Edward G., Najjar, Samer S., Harrington, Robert A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2010
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3018783/
https://ncbi.nlm.nih.gov/pubmed/21095264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2010.09.007
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg